SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-019923
Filing Date
2021-06-04
Accepted
2021-06-04 16:37:54
Documents
5
Period of Report
2021-06-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10025496_8k.htm 8-K 28035
2 EXHIBIT 99.1 brhc10025496_ex99-1.htm EX-99.1 11988
3 EXHIBIT 99.2 brhc10025496_ex99-2.htm EX-99.2 10656
4 image0.jpg GRAPHIC 963
5 image00001.jpg GRAPHIC 2533
  Complete submission text file 0001140361-21-019923.txt   56873
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38787 | Film No.: 21997011
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences